CA2010982A1 - Promotion de l'osteogenese par l'utilisation de derives de vitamine d - Google Patents

Promotion de l'osteogenese par l'utilisation de derives de vitamine d

Info

Publication number
CA2010982A1
CA2010982A1 CA2010982A CA2010982A CA2010982A1 CA 2010982 A1 CA2010982 A1 CA 2010982A1 CA 2010982 A CA2010982 A CA 2010982A CA 2010982 A CA2010982 A CA 2010982A CA 2010982 A1 CA2010982 A1 CA 2010982A1
Authority
CA
Canada
Prior art keywords
vitamin
derivatives
osteogenesis promotion
hydrogen atom
hydroxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2010982A
Other languages
English (en)
Other versions
CA2010982C (fr
Inventor
Toshio Matsumoto
Yasuho Nishii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CA2010982A1 publication Critical patent/CA2010982A1/fr
Application granted granted Critical
Publication of CA2010982C publication Critical patent/CA2010982C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002010982A 1989-02-28 1990-02-27 Promotion de l'osteogenese par l'utilisation de derives de vitamine d Expired - Fee Related CA2010982C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP48098/1989 1989-02-28
JP4809889 1989-02-28

Publications (2)

Publication Number Publication Date
CA2010982A1 true CA2010982A1 (fr) 1990-08-31
CA2010982C CA2010982C (fr) 2000-06-13

Family

ID=12793841

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010982A Expired - Fee Related CA2010982C (fr) 1989-02-28 1990-02-27 Promotion de l'osteogenese par l'utilisation de derives de vitamine d

Country Status (6)

Country Link
US (1) US5053401A (fr)
EP (1) EP0385446B1 (fr)
AT (1) ATE131061T1 (fr)
CA (1) CA2010982C (fr)
DE (1) DE69023939T2 (fr)
HK (1) HK1005015A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
AU666529B2 (en) * 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
KR960013798B1 (ko) * 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 평면 도파로형 공간 스위치
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
ES2173911T3 (es) * 1992-12-29 2002-11-01 Michael F Holick Uso de glicosidos en vitamina d para el tratamiento o prevencion de la osteoporosis.
JP4125869B2 (ja) * 1998-02-03 2008-07-30 アレヴァ エンペー ゲゼルシャフト ミット ベシュレンクテル ハフツング 蓄圧タンクおよび加圧流体の準備方法
AUPP794898A0 (en) * 1998-12-24 1999-01-28 Garvan Institute Of Medical Research Transgenic animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332841C (fr) * 1984-11-27 1994-11-01 Noboru Kubodera Derives de vitamine d et procede de production
JPS61267550A (ja) 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体

Also Published As

Publication number Publication date
CA2010982C (fr) 2000-06-13
EP0385446B1 (fr) 1995-12-06
US5053401A (en) 1991-10-01
ATE131061T1 (de) 1995-12-15
DE69023939D1 (de) 1996-01-18
EP0385446A2 (fr) 1990-09-05
DE69023939T2 (de) 1996-05-09
EP0385446A3 (fr) 1991-10-30
HK1005015A1 (en) 1998-12-18

Similar Documents

Publication Publication Date Title
IL99889A0 (en) Azasteroid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IE890906L (en) Method of lowering the blood pressure
AU3945589A (en) Substituted 4-piperidinyl-indol-5-yl-alkyl-sulphonamide derivatives
GR3030165T3 (en) N-heteroaryl-n'-phenylurea derivatives, their production and use.
AU586691B2 (en) Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them
CA2015473A1 (fr) Derives de triphenylmethane
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ATE161848T1 (de) Glycyrrheticsäurederivate
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
DE69012620D1 (de) Unterdrückung der Synthese und der Sekretion des Nebenschilddrüsenhormons mit Vitamin D3-Derivaten.
EP0388956A3 (fr) Dérivé de phtalinide, composition pharmaceutique et utilisation
EP0531016A3 (en) Polysulfate of beta-cyclodextrin derivative and process for preparing the same
TW223016B (fr)
EP0414422A3 (en) 2-oxo-1-oxa-8-azaspiro (4,5) decane derivatives, processes for their preparation and pharmaceutical compositions thereof
DE69023939D1 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
HUT57694A (en) Process for producing new beta-diketones and pharmaceutical compositions comprising same
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
AU4459296A (en) 2-substituted vitamin d3 derivatives
GR3005961T3 (fr)
EP0312353A3 (en) Zearalanol derivatives with anabolic activity
HUT58269A (en) Process for producing aralkyl-amine derivatives and pharmaceutical compositions containing them as active components
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
MX9601163A (es) Nuevos compuestos derivados de cromeno.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed